Physician profile
Jasmine Nguyen
NPI 1922620186
$2,798.72
in general payments reported to CMS, 2019-2025
14 companies · $36.59 in 2025
The $36.59 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $238 · 2021: $1,081 · 2022: $664 · 2023: $760 · 2024: $18.70 · 2025: $36.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $723.64 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $422.65 | 2021-2023 | Cequa, Xelpros |
| Oyster Point Pharma, INC. | $331.94 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $234.70 | 2021 | |
| Eyevance Pharmaceuticals LLC | $201.31 | 2021-2022 | |
| Dompe US, INC. | $182.69 | 2022-2023 | Oxervate |
| Bausch & Lomb Americas INC. | $143.99 | 2023-2025 | Infuse |
| Kala Pharmaceuticals, INC. | $139.03 | 2021 | |
| Sight Sciences, INC. | $121.30 | 2023 | Omni Surgical System |
| Alcon Vision LLC | $100.14 | 2022-2023 | Total30 |
| Coopervision INC. | $85.83 | 2023-2025 | Onefit Contact Lens, Paragon Crt, Myday Contact Lens |
| Abbvie INC. | $52.05 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $34.50 | 2022 | |
| Thea Pharma INC. | $24.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.